TrialSignal
Clinical trial intelligence report
Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT00687882
Status
COMPLETED
Phase
PHASE3
Sponsor
Johns Hopkins All Children's Hospital
Executive brief
Investment-Ready Snapshot
The Kids-DOTT trial evaluates the non-inferiority of a shortened duration (6 weeks) versus conventional duration (3 months) of anticoagulation therapy in children with first-episode acute venous thrombosis. The study aims to enroll 750 children across 40 centers, focusing on safety and efficacy outcomes related to recurrent venous thromboembolism (VTE) and bleeding.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT00687882
Indication
Venous Thrombosis
Modality
monoclonal antibody
Target
Venous Thrombosis in Children
Intervention
Shortened duration (6 weeks) of anticoagulant therapy, Conventional duration (3 months) of anticoagulant therapy, No Intervention, No Intervention
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.